跳至主要内容
临床试验/NCT00900913
NCT00900913已完成4 期

Effect of Systemic Ropivacaine on Hyperalgesia, Flare Reaction and Peripheral

University of Zurich1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2010年1月1日最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
34
试验地点
1
主要终点
Aera of flare reaction (cm2), area of primary and secondary hyperalgesia (cm2)

研究概览

简要总结

The purpose of this study is to compare the effect of intravenous ropivacaine and lidocaine on the receptive field of primary sensory afferents and their influence on the vascular bed.

*Trial with medicinal product

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Age: 18 - 65 years
  • Weight: 50-100kg
  • Height: 155-195cm
  • Signed and dated informed consent
  • Sufficient command of German language

排除标准

  • Contraindications to the class of drugs under study
  • Vulnerable subjects (intellectually or mental impaired)
  • Known hypersensitivity to class of drugs or the investigational product
  • Known peripheral neuropathies
  • Diabetes mellitus
  • Chronic alcohol consumption
  • Congestive heart disease
  • Participants of other studies during study period

结局指标

主要结局

Aera of flare reaction (cm2), area of primary and secondary hyperalgesia (cm2)

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验